Latin America IVF Market

Latin America IVF Market Size (2024 to 2029)

The size of the Latin America IVF Market is expected to reach USD 0.56  billion by 2029 from USD 0.25 billion in 2024, growing at a CAGR of 17.6% from 2024 to 2029.

Several factors support the growth of the Latin American IVF market, namely, owing to the growing knowledge of IVF treatment, low-cost healthcare facilities, the large base of the population facing infertility, and an increase in disposable income. In addition, several medical conditions such as diabetes, hypothyroidism, hyperthyroidism, anemia, cancer, artificial hormonal therapy, polycystic ovarian syndrome, and other genetic disorders affect the fertility of an individual. In 2018, 1.70 million incident cases of PCOS were reported among women of childbearing age of 15-49 years across the globe, representing an increase of 4.47% from 2007 to 2017. According to a study, the prevalence of PCOS among women receiving treatment in Brazil was over 8.7%. Also, the recent increase in obesity rates may be contributing to the increased incidence of PCOS in the region, as the previous report that the prevalence of PCOS is 2-3 times higher in obese women than in their non-obese counterparts.

Factors such as awareness about infertility, timely and accurate diagnosis, better education of healthcare professionals and patients, improved screening and diagnostic protocols, and earlier treatment will result in lesser complications and ultimately reduce the infertility rate in Latin America. According to recent estimates by the United Nations in 2018, nearly half of the world's population lives in countries with low fertility. Furthermore, the number of countries with fertility below replacement level has increased significantly in the past forty years, from less than ten in the early 1980s to over eighty. Therefore, the upward trend of late pregnancies among women is expected to drive the growth of the Latin American IVF market. In addition, an increase in the number of fertility clinics is giving patients opportunities to try new treatment options, which is responsible for driving the studied market in the future.

However, complications associated with in-vitro fertilization such as multiple pregnancies and congenital disabilities, increased hospital stay, the social stigma associated with infertility, and lower awareness of IVF in some underdeveloped regions hamper the market growth.

This research report on the Latin America IVF Market has been segmented and sub-segmented into the following categories:

By Reagents and Media: 

• Embryo Culture Media
• Cryopreservation Media
• Sperm Processing Media
• Ovum Processing Media                   

By Instruments: 

• Imaging Systems
• Sperm Separation Systems
• Ovum Aspiration Pumps
• Incubators
• Micromanipulator Systems
• Cryosystems
• Other Instruments (Gas Analyzers, Laser Systems, Accessories)                     

By Technology: 

• Intra-Cytoplasmic Sperm Injection (ICSI)
• Pre-Implantation Genetic Diagnosis (PGD)
• Frozen Embryo Transfer/Replacement (FET/FER)
• Other Technologies                             

By End Users: 

• Fertility and Surgical Centers
• Hospitals and Research Laboratories
• Cryobanks                               

By Country:

• Brazil
• Mexico
• Argentina
• Chile
• Rest of Latin America

The Brazilian market is expected to experience significant growth during the forecast period, owing to increasing infertility rates among the population. Brazil is the most developed country and has a higher number of clinics and hospitals with advanced technologies. In addition, the region has a significant share of revenues from medical tourism from the other areas, and this trend is anticipated to remain over the forecast period. Apart from this, high alcohol consumption, smoking, obesity, stress, and other lifestyle-related illnesses have dramatically increased the need for infertility treatments. Hence, all these factors are expected to support the development of the IVF Market in Brazil.

In Mexico, the growth of the studied market is supported by factors such as the increasing number of infertility cases, high incidence of PCOS, rising obesity levels, pollution, drugs and alcohol abuse, and a growing number of smokers. The region also has strict abortion rules, which directly affects the fertility rate due to unsuccessful and misguided treatment options. Above all, the increasing number of clinically advanced fertility centers is adding to the market's growth. For example, the LIV Fertility Center offers semen analysis, semen treatment, and medication assistance. In addition, advanced techniques such as sperm sorting technology, and day-to-day hormonal and egg analysis help to maximize the success rate of a single IVF cycle. Other regions in Latin America such as Cambodia, Puerto Rico, Ecuador, and Argentina are also anticipated to have a steady market growth rate owing to the generally improving awareness about infertility in the population of these regions, along with advancing healthcare infrastructure with skilled doctors.

KEY MARKET PLAYERS

Companies playing a pivotal role in the Latin American IVF Market covered in this report are CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.).